Key facts
- Livespire’s last known valuation is $480K (Mar 2024).
- It has raised $3.7M; the latest was Early Stage VC ($2.3M) in Sep 2025.
- Notable investors include Namita Thapar, PointOne Capital, GSF India, ah! Ventures, IvyCap Ventures — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Livespire
- ·The full record, as it builds
Funding rounds
No funding rounds for Livespire are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Livespire
Developer of an AI-powered chronic pain management platform designed to provide long-term, sustainable relief through personalized online physiotherapy and health practices. The company's platform offers one-on-one therapy sessions combining physiotherapy, yoga therapy, and real-time AI assessments, enabling individuals suffering from chronic conditions like back pain, cervical issues, and joint stiffness to achieve improved mobility, mental clarity, and overall well-being.
- Sector
- Healthcare
- HQ
- Pune, India
- Founded
- 2021
- Employees
- 97
- Website
- flexifyme.com/
- Ownership
- Privately Held (backing)
Livespire doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Livespire shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Livespire in its N-PORT filings yet. We sweep new filings monthly.